Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › XBP1, CD138, and CS1 peptides

XBP1, CD138, and CS1 peptides

US Patent 11083783 · Granted Aug 10, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T cell receptors specific to b-cell maturation antigen for treatment of cancer2025
Modulating gabarap to modulate immunogenic cell death2024
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
Methods for modulating regulatory T cells, regulatory b cells, and immune respon2024
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Immunogenic peptides specific to BCMA and TACI antigens2022
Immunogenic peptides specific to BCMA and TACI antigens2022
Immunogenic peptides specific to BCMA and TACI antigens2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
USP7 inhibitors for treating multiple myeloma2022
Inhibitors of histone deacetylase2022